DK0622366T3 - Kondenserede quinolyl-dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler til behandling af hjerte-kredsløbssygdomme - Google Patents

Kondenserede quinolyl-dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler til behandling af hjerte-kredsløbssygdomme

Info

Publication number
DK0622366T3
DK0622366T3 DK94105778.8T DK94105778T DK0622366T3 DK 0622366 T3 DK0622366 T3 DK 0622366T3 DK 94105778 T DK94105778 T DK 94105778T DK 0622366 T3 DK0622366 T3 DK 0622366T3
Authority
DK
Denmark
Prior art keywords
preparation
treatment
condensed
dihydropyridines
quinolyl
Prior art date
Application number
DK94105778.8T
Other languages
Danish (da)
English (en)
Inventor
Siegfried Dr Goldmann
Alexander Dr Straub
Martin Dr Bechem
Rainer Prof Dr Gross
Howard-Paul Dr Rounding
J Stolefuss
Siegbert Dr Hebisch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0622366T3 publication Critical patent/DK0622366T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
DK94105778.8T 1993-04-27 1994-04-14 Kondenserede quinolyl-dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler til behandling af hjerte-kredsløbssygdomme DK0622366T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4313690A DE4313690A1 (de) 1993-04-27 1993-04-27 Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln

Publications (1)

Publication Number Publication Date
DK0622366T3 true DK0622366T3 (da) 1997-05-12

Family

ID=6486449

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94105778.8T DK0622366T3 (da) 1993-04-27 1994-04-14 Kondenserede quinolyl-dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler til behandling af hjerte-kredsløbssygdomme

Country Status (20)

Country Link
US (1) US5436342A (fr)
EP (1) EP0622366B1 (fr)
JP (1) JPH06321939A (fr)
CN (1) CN1098721A (fr)
AT (1) ATE145903T1 (fr)
AU (1) AU5922594A (fr)
CA (1) CA2121980A1 (fr)
CZ (1) CZ99494A3 (fr)
DE (2) DE4313690A1 (fr)
DK (1) DK0622366T3 (fr)
ES (1) ES2096368T3 (fr)
FI (1) FI941911A (fr)
GR (1) GR3022026T3 (fr)
HU (1) HUT70488A (fr)
IL (1) IL109417A0 (fr)
MX (1) MX9403032A (fr)
NO (1) NO941514L (fr)
NZ (1) NZ260383A (fr)
SK (1) SK48094A3 (fr)
ZA (1) ZA942883B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL320263A1 (en) 1994-11-16 1997-09-15 Synaptic Pharma Corp Dihydropyrimidines and their application
US6268369B1 (en) 1994-11-16 2001-07-31 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6228861B1 (en) 1995-11-16 2001-05-08 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6172066B1 (en) 1996-05-16 2001-01-09 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6245773B1 (en) 1996-05-16 2001-06-12 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6680323B2 (en) 1998-12-23 2004-01-20 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6274585B1 (en) 1998-12-23 2001-08-14 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6518279B2 (en) 1999-03-04 2003-02-11 Abbott Laboratories Cyclopentanone dihydropyridine compounds useful as potassium channel openers
US6720324B2 (en) 2000-07-05 2004-04-13 Synaptic Pharmaceutical Corporation Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
WO2005025507A2 (fr) * 2003-09-10 2005-03-24 Synta Phamaceuticals Corp. Composes de dihydropyridine permettant de traiter ou de prevenir des troubles metaboliques
CA2752603C (fr) 2009-02-18 2016-04-05 Bayer Pharma Aktiengesellschaft Derives de 1,4-dihydropyridine substitues par indazole bi- et tricycliques et leurs utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3412947A1 (de) * 1984-04-06 1985-10-17 Bayer Ag, 5090 Leverkusen Tetrahydothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US5204472A (en) * 1990-04-06 1993-04-20 Bayer Aktiengesellschaft Quinoline and isoquinoline intermediates
DE4011105A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue 4-chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
HUT70488A (en) 1995-10-30
NO941514L (no) 1994-10-28
FI941911A (fi) 1994-10-28
CZ99494A3 (en) 1995-01-18
MX9403032A (es) 1995-01-31
NZ260383A (en) 1996-02-27
SK48094A3 (en) 1994-12-07
US5436342A (en) 1995-07-25
IL109417A0 (en) 1994-07-31
GR3022026T3 (en) 1997-03-31
DE4313690A1 (de) 1994-11-03
AU5922594A (en) 1994-11-03
DE59401179D1 (de) 1997-01-16
NO941514D0 (fr) 1994-04-26
ES2096368T3 (es) 1997-03-01
ZA942883B (en) 1995-01-16
EP0622366A1 (fr) 1994-11-02
CN1098721A (zh) 1995-02-15
HU9401193D0 (en) 1994-07-28
JPH06321939A (ja) 1994-11-22
EP0622366B1 (fr) 1996-12-04
ATE145903T1 (de) 1996-12-15
CA2121980A1 (fr) 1994-10-28
FI941911A0 (fi) 1994-04-25

Similar Documents

Publication Publication Date Title
DK1140945T3 (da) Kondenserede 1,2,4-thiadiazinderivater, deres fremstilling og anvendelse
DK256890A (da) Benzo-piperidin-, -piperidyliden- og piperazinforbindelser, kompositioner indeholdende forbindelserne og fremgangsmaader til forbindelsernes fremstilling og anvendelse
LU92146I2 (fr) Dasatinib et ses sels pharmaceutiquement acceptables
DK0807633T3 (da) Hidtil ukendte 2,3-disubstituerede-(5,6)-heteroarylkondenserede pyrimidin-4-oner
DK0622366T3 (da) Kondenserede quinolyl-dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler til behandling af hjerte-kredsløbssygdomme
DK217588A (da) 17beta-(cyclopropylamino)-androst-5-en-3beta-olderivater, deres fremstilling og anvendelse som laegemidler
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
NO995431L (no) Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse
DK0870761T3 (da) Thiocolchicinderivater med antiinflammatoriske og muskelafslppende aktiviteter
NO881308L (no) Dihydropyridinamider, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DK0703232T3 (da) 2,3-Dihydro-1H-isoindolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som hæmmere af serotoningenoptagelsen
DE60231054D1 (de) Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält
MA23392A1 (fr) Isopropyl2-methoxyethyl 4-(2-chloro-3-cianopenyl)-1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylate
DK0523013T3 (da) Anvendelse af benzimidazolin-2-oxo-1-carboxylsyrederivater ved behandling af organiske mentale sygdomme
ATE158576T1 (de) Alpha-aryl-alpha-hydroxy-beta- imidazolinylpropionsäureamide
NO993126L (no) Anvendelse av benzoylalkyl-1,2,3,6-tetrahydropyridiner